Health News Releases

  • Today May 21
October 27, 2015 14:25
1abtik ag Founded to Fight Sepsis with Novel Antibody Therapeutics
The 1abtik ag was recently founded with the sole focus to develop a game-changing antibody-based therapy for sepsis. 1abtik has now entered the financing phase for the drug development process ranging
October 27, 2015 11:55
Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at UEG Week
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today presented results from the maintenance phase of the TOUCHSTONE phase 2 clinical trial of Ozanimod, an
October 23, 2015 13:40
Quintiles and IMS Health Announce Global Collaboration to Advance the Use of Next-Generation Real-World Evidence in Late-Stage Clinical Research
Quintiles and IMS Health today announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-
October 23, 2015 12:00
Masimo & Atheer to Demonstrate Prototype of Interactive Root® Iris™ Display Powered by AiR™ Smart Glasses Platform
Masimo (NASDAQ: MASI) and Atheer announced today that they will unveil a prototype of the Root Iris display App using the Atheer AiR (Augmented interactive Reality) platform and AiR Glasses at the Ame
October 23, 2015 10:30
Asia MannaFest Sets the Tone for Mannatech’s Expansion Plans
Mannatech, Incorporated (http://us.mannatech.com) (NASDAQ: MTEX http://goo.gl/SP6Q2G), the founder of the M5M℠ (Mission 5 Million℠) Foundation (http://m5mfoundation.org), the pioneer of nutritional gl
October 20, 2015 16:40
Quintiles Names Kevin Gordon as COO, Appoints Mike McDonnell as CFO
Quintiles announced that Kevin Gordon, currently serving as Executive Vice President, Operations and Chief Financial Officer (CFO), has been promoted to Chief Operating Officer (COO) and that Michael
October 20, 2015 14:40
Adare Pharmaceuticals Appoints James Jogerst as Vice President, Corporate Development
Adare Pharmaceuticals, Inc. announced today that James (Jim) Jogerst has joined the Company as Vice President, Corporate Development. He will be based at the Company’s headquarters in Princeton, NJ.
October 20, 2015 11:50
Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at ACG Plenary Session
Celgene Corporation (NASDAQ: CELG) today announced detailed results from the maintenance phase of the TOUCHSTONE phase 2 clinical trial of Ozanimod, an investigational compound, in patients with moder
October 19, 2015 18:15
FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate)
Boehringer Ingelheim GmbH announced the U.S. Food and Drug Administration (FDA) granted approval of Praxbind® (idarucizumab).[4] Praxbind® is indicated for patients treated with Pradaxa® (dabigatran e
October 19, 2015 13:55
New CPR Guidelines Recommend Using Social Media and Mobile Technology to Speed Bystander CPR in Sudden Cardiac Arrests
For the first time, CPR guidelines (https://goo.gl/6vMmWF) issued by the American Heart Association (AHA) recommend that communities consider using social media and mobile app technology to alert CPR
October 16, 2015 17:50
Quintiles Named 2015 Frost & Sullivan Asia Pacific CRO Company of the Year
Citing Quintiles' (www.quintiles.com) innovation, customer service and growth, Frost & Sullivan has named Quintiles as its Asia Pacific Contract Research Organization Company of the Year. “Quintile
October 16, 2015 11:40
GN ReSound and Cochlear Limited Establish Smart Hearing Alliance to Develop and Commercialise Bimodal Solutions
GN ReSound, the leader in Smart Hearing™ aids, and Cochlear Limited (ASX:COH), the global leader in implantable hearing solutions, today announced a strategic alliance to develop the world’s smartest
October 15, 2015 13:45
Quintiles Recognized as Phase I Services Leader for Third Consecutive Year
For the third year in a row, Quintiles has been named the industry leader in Phase I services according to respondents in Industry Standard Research’s (ISR) 2015 CRO Quality Benchmarking - Phase I Ser
October 14, 2015 13:50
Cell Signaling Technology Expands Portfolio with GMP Capabilities
Cell Signaling Technology, Inc. (CST), a worldwide provider of high quality antibodies, announced today that their best-in-class recombinant rabbit monoclonal antibodies, developed with their propriet
October 14, 2015 13:45
CardioKinetix Announces South Korean Approval for the Parachute System for Heart Failure
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that it has received regulatory approval for the Parachute® System in South Korea
October 14, 2015 13:30
Joe Kiani to Deliver Keynote Address at Brazil’s Inaugural Foundation for Patient Safety Symposium
The Society of Anesthesiology of the State of São Paulo (SAESP) announced today that Joe Kiani, Founder of the Patient Safety Movement Foundation, will deliver the keynote address at the first annual
October 13, 2015 13:55
Quintiles Wins Society for Clinical Research Sites’ 2015 Eagle Award
Quintiles today announced that it has been awarded the Society for Clinical Research Sites’ (SCRS) 2015 Clinical Research Organization (CRO) Eagle Award. Presented during the annual SCRS Site Solution
October 13, 2015 09:50
One Year Data from Phase III Study Evaluating Oral OTEZLA® (apremilast) or Injectable etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at EADV
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that results from its ongoing phase III LIBERATE™ trial evaluating Otezla® (apremilast), th
October 12, 2015 14:40
New Cancer Research Funding Effort Announced by Feld Entertainment and Primary Children’s Hospital
The Feld Family, owners of Feld Entertainment, Inc., the parent company of Ringling Bros. and Barnum & Bailey® and the Ringling Bros. Center for Elephant Conservation®, announced yesterday a new fundi
October 12, 2015 13:30
Feld Entertainment and Primary Children’s Hospital Announce New Cancer Research Funding Effort
The Feld Family, owners of Feld Entertainment, Inc., the parent company of Ringling Bros. and Barnum & Bailey® and the Ringling Bros. Center for Elephant Conservation®, announced today a new funding e
October 12, 2015 11:20
Masimo PVI® Evaluated in 18-Study Meta-Analysis for Ability to Help Clinicians Assess Fluid Responsiveness
Masimo (www.masimo.com) (NASDAQ: MASI) announced today that an 18-study meta-analysis of 665 subjects reported that Masimo’s Pleth Variability Index (PVI®), available with Masimo’s SET® and rainbow® S
October 12, 2015 09:25
Celgene Announces New Data for OTEZLA® (Apremilast) Will Be Presented at European Academy of Dermatology and Venereology Congress
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the latest research on Otezla® (apremilast), the Company's oral, selective inhibitor of
October 09, 2015 12:45
Boehringer Ingelheim’s investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study
New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim’s investigational biologic compound BI 655066*, over ustekinumab. After nine months, 69 percen
October 09, 2015 12:20
Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Recombinant Technology and to Become a Minority Shareholder of Glycotope GmbH Berlin
Octapharma AG invests €80 million to acquire an exclusive worldwide license to certain IP of Glycotope’s recombinant technology and to become a minority shareholder of Glycotope GmbH Berlin. This S
October 08, 2015 17:45
Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma
Merck and Pfizer today announced that the US Food and Drug Administration (FDA) has granted avelumab*, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Fast Track designation for th
25 per page50 per page75 per page100 per page